← Back to Search

Artificial Intelligence

AI Algorithm for Contact Dermatitis

N/A
Recruiting
Led By Matthew Hall, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Currently taking immunosuppression agents or is immunocompromised due to medical condition
No sunburn or rash at site of testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to make remote patch allergy testing more effective and convenient for people to use at home."

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am on immunosuppressants or have a condition that weakens my immune system.
Select...
I don't have a sunburn or rash where the test will be done.
Select...
I am not pregnant or breastfeeding.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Classification of test site region reaction
Secondary study objectives
Adverse events related to allergen exposure
Classification of test site region using a 5-point scale
Early termination of testing
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: DermAI and Patch Allergen TestingExperimental Treatment2 Interventions
Subjects will have two allergen patches on their forearms for 48 hours and a photograph image of where the patches were placed afterwards for human review and AI predictions of reactions.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,343 Previous Clinical Trials
3,062,199 Total Patients Enrolled
Matthew Hall, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
233 Total Patients Enrolled
~100 spots leftby Nov 2025